Oncopharmpod
Epcoritamab
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:15:32
- Mas informaciones
Informações:
Sinopsis
We discuss the newly approved CD20-CD3 T-cell engager for subcutaneous (SC) administration to treat DLBLC after 2 or more lines of therapy.
